Skip to main content
Erschienen in: Calcified Tissue International 4/2020

Open Access 04.01.2020 | Original Research

Age- and Strain-Related Differences in Bone Microstructure and Body Composition During Development in Inbred Male Mouse Strains

verfasst von: Maria Papageorgiou, Ursula Föger-Samwald, Katharina Wahl, Katharina Kerschan-Schindl, Peter Pietschmann

Erschienen in: Calcified Tissue International | Ausgabe 4/2020

Abstract

We explored age- and strain-related differences in bone microstructure and body composition in male C57BL/6J, DBA/2JRj and C3H/J mice. Bone microstructure of the femur, tibia and L4 was assessed by μCT at the age of 8, 16 and 24 weeks. The weight of several muscles and fat depots were measured at the same time points. At all timepoints, C3H/J mice had the thickest cortices followed by DBA/2JRj and C57BL/6J mice. Nevertheless, C57BL/6J mice had higher Tb.BV/TV and Tb.N, and lower Tb.Sp than DBA/2JRj and C3H/J mice at least at 24 weeks of age. Skeletal development patterns differed among strains. C57BL/6J and DBA/2JRj mice, but not C3H/J mice, experienced significant increases in the sum of the masses of 6 individual muscles by 24 weeks of age. In C57BL/6J and DBA/2JRj mice, the mass of selected fat depots reached highest values at 24 weeks, whist, in C3H/J mice, the highest values of fat depots masses were achieved at 16 weeks. Early strain differences in muscle and fat masses were largely diminished by 24 weeks of age. C3H/J and C57BL/6J mice displayed the most favorable cortical and trabecular bone parameters, respectively. Strain differences in body composition were less overt than strain specificity in bone microstructure, however, they possibly influenced aspects of skeletal development.
Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s00223-019-00652-8) contains supplementary material, which is available to authorized users.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ANOVA
Analysis of variance
ASBMR
American Society for Bone and Mineral Research
BMC
Bone mineral content
BMD
Bone mineral density
Ct.Ar
Cortical bone area
Ct.Ar/Tt.Ar
Cortical bone area fraction
Ct.Th
Average cortical thickness
DXA
Dual-energy X-ray absorptiometry
EDL
M. extensor digitorum longus
ELISA
Enzyme-linked immunosorbent assay
GAS
M. gastrocnemius
GASP-1
Growth and differentiation factor-associated serum protein 1
HR-pQCT
High-resolution peripheral quantitative computed tomography
IL-6
Interleukin 6
LTBP3
Latent transforming growth factor β binding protein 3
L4
4th Vertebral body
L5
5th Vertebral body
QUAD
M. quadriceps femoris
SE
Standard error
SOL
M. soleus
SPSS
Statistical package for the social sciences
TA
M. tibialis anterior
Tb.BV/TV
Trabecular bone volume/tissue volume
Tb.N
Trabecular number
Tb.Th
Trabecular thickness
Tb.Sp
Trabecular separation
TMD
Tissue mineral density
TNF-a
Tumor necrosis factor alpha
TRIC
M. triceps brachii
Tt.Ar
Total cross-sectional area
Tukey’s HSD
Tukey’s honestly significant difference
Wnt
Wingless-related integration site
μCT
Micro-computed tomography

Introduction

Childhood and adolescence are critical periods for the accrual of peak bone mass and structure, defined as the maximal values of skeletal traits present at the end of skeletal maturation [13]. Twin and family studies suggest that 60–80% of peak bone mass variability is attributable to genetic factors, whilst up to 40% of the remaining variability can be influenced by modifiable factors such as lifestyle and body composition [1, 3]. Given that peak bone characteristics may have lifelong influences on bone properties and affect osteoporotic fracture risk later in life [2, 3], a thorough understanding of their determinants is required for the development of novel strategies to combat osteoporosis and prevent fragility fractures.
Among other modifiable factors, the relationship between body composition (muscle and fat mass) and bone during growth in humans has gained considerable interest [1, 4]. Several pediatric studies suggest that muscle mass and bone mass are closely linked during development [47]. Less clear is, however, whether muscle development is driving skeletal development (mechanostat theory) and therefore, whether the attainment of peak muscle mass precedes the acquisition of peak bone mass [810]. Studies on the relationship between fat and bone parameters in children, adolescents and young adults have revealed positive, negative or no associations [4, 11, 12]; these discrepancies may reflect methodological differences and/or perplexing bone–fat interactions. Despite the growing evidence, pediatric studies in this area are challenged by uncontrolled genetic and environmental heterogeneity, undesirable radiation exposure during longitudinal bone assessments and bone measurements restricted to certain anatomical sites (e.g., assessment of the distal radius and tibia using high-resolution peripheral quantitative computed tomography or HR-pQCT) [13].
Conversely, animal models provide unique opportunities to study aspects of skeletal health and disease. In particular, inbred mouse strains have a homogeneous genetic background (similar to identical twins) and exhibit various bone phenotypes that can be studied under stringent environmental control. Importantly, bone mass and biomechanical properties in inbred mice appear to be strain dependent [1421]. For instance, Beamer et al. demonstrated large variations in bone mineral content (BMC) and density (BMD) among 11 inbred strains of mice [14]. Profound strain differences in BMD were found between the C57BL/6J and C3H/HeJ mice, which are extensively used in skeletal research and considered low and high bone mass strains, respectively. In contrast, normal skeletal phenotypes have been poorly characterized in young DBA/2JRj mice and rarely compared to those of other mouse strains [14, 16, 17]. Strain differences have also been reported in muscle [22, 23] and fat mass [24, 25], whereas investigations that have concomitantly explored bone, muscle and fat are scarce [26].
There are surprisingly limited data on normal patterns of development, especially around skeletal maturity. Significant controversies have been reported regarding the attainment of peak bone properties, even within a given mouse strain, and most available reports have focused on C57BL/6J mice [2629]. Thus, this period requires further investigation in C57BL/6J mice, but also in other commonly used strains.
As such, we explored age-related changes and strain differences in bone microstructure, body composition and selected biomarkers during development among 3 commonly used male and female inbred mouse strains, namely C57BL/6J, DBA/2JRj and C3H mice, and in this study we report the results for the male animals. Male mice remain understudied compared to female mice [14, 17, 1921, 30], despite the fact that optimization of skeletal acquisition is crucial for both sexes and skeletal diseases affect both women and men [13].

Materials and Methods

Animals

Male C57BL/6J (Abteilung für Labortierkunde und Genetik, Himberg, Austria), DBA/2JRj (Janvier Labs, Le Genest-St-Isle, France) and C3H/J (Charles River, Sulzfeld, Germany) mice were maintained in our laboratory animal care facility and sacrificed at 8, 16 and 24 weeks of age (n = 6/group). All mice were housed in groups of 2–6 mice/cage and kept under standard conditions on a 12:12 h light/dark cycle. Water and a diet of standard laboratory chow (LASQCdiet® Rod16, Auto; LASvendi GmbH, Soest, Germany) were available ad libitum. All procedures were conducted in accordance with institutional and national guidelines. According to the Austrian animal experimentation law, permission from the Health ministry is not required for this project, since the harvesting of tissues or organs is not regarded as an animal experiment.

Tissue Collection

All mice were euthanized by carbon dioxide asphyxiation and weighed using an analytical balance. The wet weight of several muscles [M. triceps brachii (TRIC), M. quadriceps femoris (QUAD), M. tibialis anterior (TA), M. extensor digitorum longus (EDL), M. gastrocnemius (GAS) and M. soleus (SOL)] was measured using an analytical balance (Sartorius, Göttingen, Germany) at the age of 8, 16 and 24 weeks of age. Retroperitoneal, epididymal, inguinal and mesenteric fat depots were dissected, and their wet mass was weighed at the same time points. The femur and the tibia were defleshed, weighted, preserved in 4% formaldehyde for 24 h and stored in 70% ethanol until microstructural analysis. The lumbar spine was removed and preserved using the same procedures.

Bone Microstructure by Micro-Computed Tomography (μCT)

Ex vivo assessments of cortical and trabecular microstructure were performed using μCT (MicroCT 35, Scanco, Switzerland). The X-ray tube was operated at 70 kV with an intensity of 114 μA, and an exposure time of 800 ms, resulting in a resolution of 10 μm/pixel. Cortical structure was determined at the midshaft of the femur and the tibia over a length of 5% proximal and 5% distal from the middle of the bone. To determine tissue mineral density of the cortex (Ct.TMD), we used standard Scanco evaluation scripts with the following parameters: (i) Gaussian image noise filter: sigma = 0.8 and support = 1, and (ii) a global threshold > 260 mg HA/cm3. Trabecular microstructure was assessed at the distal femur, proximal tibia and lumbar spine (L4). In the distal femur, trabecular structure was scanned proximal from the epiphysis over a length of 10% of the total femur. Trabecular morphology was also assessed in the proximal tibia starting at the distal end of the growth plate and extending to a 10% at distal length of the whole tibia length. Reporting of cortical and trabecular microstructure outcomes were performed according to the American Society for Bone and Mineral Research (ASBMR) guidelines [31]. The cortical parameters assessed were average cortical thickness (Ct.Th), total cross-sectional area (Tt.Ar), cortical bone area (Ct.Ar), cortical bone area fraction (Ct.Ar/Tt.Ar) and Ct.TMD. The trabecular microstructural parameters assessed were trabecular bone volume/total volume (Tb.BV/TV), number (Tb.N), thickness (Tb.Th), trabecular separation (Tb.Sp), connectivity density (Conn.D), trabecular mineral density (Tb.TMD) and structure model index (SMI).

Blood Collection and Biochemical Analysis

Blood samples were obtained immediately after carbon dioxide asphyxiation. Animals were not fasted prior to blood collection. After centrifugation, serum was isolated and stored at − 80 °C until further analysis for myostatin and periostin levels. Both markers are emerging candidates of muscle/bone crosstalk [3236], nevertheless, it remains largely unexplored whether/how periostin and myostatin levels change during the period around peak attainment of musculoskeletal traits. Serum myostatin (R&D Systems, Abingdon, United Kingdom) and periostin (Biomedica Medizinprodukte GmbH, Vienna, Austria) levels were measured by enzyme-linked immunosorbent assay (ELISA) according to manufacturers’ instructions. Myostatin inter-assay CV was ≤ 6% between 31.3 and 2000 pg/mL and the sensitivity was 5.32 pg/mL. The inter-assay CV for periostin was ≤ 6% between 0 and 16 nmol/L and the detection limit was 0.003 nmol/L.

Statistical Analysis

All variables were checked for normality using the Shapiro–Wilk test. Values are presented as mean and standard error (SE). For normally distributed data, two-way analysis of variance (ANOVA) was used to assess the main effects of strain and age, and their interaction on skeletal and body composition characteristics and biochemical markers. Tukey’s (honestly significant difference) HSD post hoc test was used to locate significant main effects. In case of a significant interaction effect, one-way ANOVA was performed to evaluate age-related changes within each strain and strain differences at each time point. For non-normally distributed data, Kruskal–Wallis and Mann–Whitney tests were used. A maximal value (median) in skeletal, body composition, and biochemical parameters was statistically identified, if there was a significant effect of age within each strain using a one-way ANOVA or Kruskal–Wallis test. To estimate effect sizes, Cohen's d was determined by calculating the mean difference between your two groups, and then dividing the result by the pooled standard deviation. Cohen’s d = 0.2 is considered a 'small' effect size, 0.5 represents a 'medium' effect size and ≥ 0.8 a 'large' effect size (Supplementary Tables 1 and 2). All analyses were performed using the statistical package for social sciences (SPSS) version 24.0 (Chicago, IL, USA) with statistical significance set at p ≤ 0.05.
Table 1
Timing of maximal/minimal values of cortical bone characteristics within the timeframe of the study (8–24 weeks of age)
  
Femur
Tibia
8 weeks
16 weeks
24 weeks
8 weeks
16 weeks
24 weeks
Maximal Ct.Th
C57BL/6J
  
x
  
x
DBA/2JRj
  
x
  
x
C3H/J
  
x
  
x
Maximal Ct.TMD
C57BL/6J
  
x
  
x
DBA/2JRj
  
x
  
x
C3H/J
  
x
  
x
Maximal Tt.Ar
C57BL/6J
  
x
  
x
DBA/2JRj
  
x
 
x
 
C3H/J
 
x
   
x
Maximal Ct.Ar
C57BL/6J
  
x
  
x
DBA/2JRj
  
x
 
x
 
C3H/J
 
x
   
x
Maximal Ct.Ar/Tt.Ar
C57BL/6J
  
x
  
x
DBA/2JRj
  
x
  
x
C3H/J
 
x
   
x
Cortical structure was determined at the midshaft of the femur and the tibia. A maximal/minimal value (median) was statistically identified, if there was a significant effect of age within each strain using a one-way ANOVA or Kruskal–Wallis test. Crosses denote that maximal/minimal value (median) was achieved at 8, 16 or 24 weeks of age; absence of crosses indicate that we did not statistically identify a maximal/minimal value within the timeframe of the study
Ct.Th average cortical thickness, Ct.Ar cortical bone area, Ct.TMD cortical tissue mineral density, Tt.Ar total cross-sectional area, Ct.Ar/Tt.Ar cortical bone area fraction (one column)
Table 2
Timing of maximal/minimal values of trabecular bone characteristics within the timeframe of the study (8–24 weeks of age)
  
Femur
Tibia
Lumbar spine
8 weeks
16 weeks
24 weeks
8 weeks
16 weeks
24 weeks
8 weeks
16 weeks
24 weeks
Maximal Tb.BV/TV
C57BL/6J
     
x
  
x
DBA/2JRj
x
   
x
  
x
 
C3H/J
x
      
x
 
Maximal Tb.N
C57BL/6J
      
x
  
DBA/2JRj
x
  
x
  
x
  
C3H/J
x
      
x
 
Maximal Tb.Th
C57BL/6J
  
x
  
x
  
x
DBA/2JRj
     
x
 
x
 
C3H/J
     
x
   
Minimal
Tb.Sp
C57BL/6J
         
DBA/2JRj
x
  
x
  
x
  
C3H/J
x
      
x
 
Trabecular bone microstructure was assessed at the distal femur, proximal tibia and forth vertebral body (L4). A peak value (median) was statistically identified, if there was a significant effect of age within each strain using a one-way ANOVA or Kruskal-Walis test. Crosses denote that maximal/minimal value (median) was achieved at 8, 16 or 24 weeks of age; absence of crosses indicate that we did not statistically identify a maximal/minimal value
Tb.BV/TV trabecular bone volume/tissue volume, Tb.N trabecular number, Tb.Th trabecular thickness, Tb.Sp trabecular separation (two columns)

Results

Body Weight

In all mouse strains, body weight increased over the time frame of the study (8 < 24 weeks of age) (Fig. 1, Supplementary Table 3). At 8 weeks of age, C3H/J mice had higher body weights than C57BL/6J, and at 16 weeks, C3H/J mice were heavier than both C57BL/6J and DBA/2JRj mice. At 24 weeks, however, there were no strain differences. This is because C57BL/6J mice experienced rapid increases in body weight after week 16 (p = 0.008), DBA/2JRj mice also experienced body weight increases, which, however, did not reach statistical significance (p = 0.071), whereas, in C3H/J mice, body weight stabilized between weeks 16 and 24 (p = 1.0).
In C57BL/6J and DBA/2JRj, Ct.Th and Ct.TMD at the femur and the tibia increased between 8 and 24 weeks, and reached maximal values at 24 weeks (Fig. 2, Table 1, Supplementary Table 4). The highest Ct.Ar/Tt.Ar occurred at 24 weeks and largely reflected the simultaneous highest values seen in Ct.Ar and Tt.Ar.
Similar cortical bone growth patterns were seen in C3H/J mice at the tibia. At the femur, Ct.Th and Ct. TMD were greatest at 24 weeks of age (Fig. 2, Table 1, Supplementary Table 4), however, Ct.Ar, Tt.Ar and Ct.Ar/Tt.Ar were highest at 16 weeks. Although there were no significant changes in Ct.Ar and Tt.Ar between weeks 16 and 24, Ct.Ar/Tt.Ar markedly decreased within this time frame, suggesting some age-related thinning of the cortex.
At both the femur and the tibia, and at all time points, C3H/J mice had the thickest cortices followed by DBA/2JRj and C57BL/6J mice (Fig. 2, Supplementary Table 4). Overall, C57BL/6J mice had smaller Ct.TMD and Ct.Ar/Tt.Ar than DBA/2JRj and C3H/J mice. Small age-related differences were found in Ct.Ar/Tt.Ar between DBA/2JRj and C3H/J mice at the tibia and the femur.
In C57BL/6J mice, Tb.BV/TV at the tibia and the lumbar spine increased between 8 and 24 weeks of age (Fig. 3, Table 2, Supplementary Table 5). The highest tibia and lumbar Tb.BV/TV were accompanied by maximal Tb.Th values at 24 weeks, whereas the effects of age on Tb.N and Tb.Sp were less consistent. The age-related effects on femoral Tb.BV/TV, Tb.N, and Tb.Sp were weak and we were not able to statistically identify highest values. Taken together, these results suggest that maximal trabecular bone properties in C57BL/6J mice occurred at 24 weeks or beyond the follow-up period of this study.
In contrast, DBA/2JRj mice experienced the highest femoral Tb.BV/TV early at 8 weeks, which appeared to be the result of greatest Tb.N and lowest Tb.Sp at this time point (Fig. 3, Table 2, Supplementary Table 5). Similar developmental patterns (highest values achieved at 8–16 weeks of age) were observed trabecular bone parameters at the tibia and lumbar spine.
Age-related changes in trabecular bone architecture in C3H/J mice were highly site specific (Fig. 3, Table 2, Supplementary Table 5). In C3H/J mice, the highest femoral Tb.BV/TV values were observed at 8 weeks; this peak paralleled the greatest Tb.N and lowest Tb.Sp. Tb.BV/TV at L4 reached a maximum at 16 weeks, similarly reflecting the highest Tb.N and the lowest Tb.Sp. Finally, tibial Tb.BV/TV and Tb.N increased and Tb.Sp decreased progressively over time. These changes, however, did not reach statistical significance, preventing us from statistically identifying maximal/minimal values for these parameters.
Between strain analyses suggest that C57BL/6J mice have higher Tb.BV/TV and Tb.N, and lower Tb.Sp than DBA/2JRj and C3H/J mice at least at 24 weeks of age at all skeletal sites (Fig. 3, Supplementary Table 3). Thus, the less favorable cortical bone characteristics in C57BL/6J mice appear to be counterbalanced by gains and rearrangement of the trabecular compartment in the longer-term. DBA/2JRj mice had consistently thinner trabeculae than C57BL/6J and C3H/J mice at all skeletal sites at least at 24 weeks of age. Less pronounced strain differences were seen in other trabecular microstructure parameters among DBA/2JRj and C3H/J mice depending on skeletal site. For example, at the femur, DBA/2JRj mice had lower Tb.N and higher Tb.Sp than C3H/J mice at 24 weeks, whereas at the lumbar spine, these parameters were higher (Tb.N)/lower (Tb.Sp) in DBA/2JRj mice compared to C3H/J mice.
C57BL/6J and DBA/2JRj mice experienced significant increases in their muscle mass (the sum of the mass of six individual muscles: M. triceps brachii, M. quadriceps femoris, M. tibialis anterior, M. extensor digitorum longus, M. gastrocnemius and M. soleus) by 24 weeks of age (Fig. 1). Age-related differences in the mass of individual muscle masses and their sum expressed in absolute terms and relative to body weight are presented in Supplementary Tables 1 and 4. In C3H/J mice, mass of individual muscles and their sum remained largely unchanged throughout this study. Overall, DBA/2JRj mice had lower muscle mass (sum or individual muscles) than C3H/J and/or C57BL/6J mice at 8 weeks of age. At 16 weeks, there were no strain differences in muscle sum or in the mass of individual muscles. At 24 weeks, C57BL/6J mice had greater site-specific muscle mass (M. gastrocnemius and M. soleus) than both DBA/2JRj and C3H/J mice, but the sum of the 6 individual muscle masses did not differ between strains.
In C57BL/6J and DBA/2JRj mice, the mass of selected fat depots (retroperitoneal, epididymal, inguinal and mesenteric), as well as their sum, increased progressively over time (greatest values observed at 24 weeks) (Fig. 1, Supplementary Table 1). In C3H/J mice, highest values of fat depots masses were largely achieved by 16 weeks of age and maintained at 24 weeks. Overall, early in the study (8 weeks), DBA/2JRj mice had heavier fat depots than C57BL/6J and C3H/J mice, however, no significant strain differences were seen in fat quantity and distribution at 24 weeks of age.
In agreement with recent findings [37], correlation analyses for strain (data pooled for time) revealed that weight was positively correlated with cortical parameters and Tb.Th in all strains (Supplementary Table 5). Positive correlations were observed between Tb.BV/TV in C57BL/6J and C3H/J, but negative correlations between these variables were seen in DBA/2JRj mice. Muscle sum was positively correlated with cortical parameters in C57BL/6J and DBA/2JRj mice. Positive correlations were seen between muscle sum and trabecular parameters in C57BL/6J (both sites) and C3H/J mice (at L4 only), whereas muscle sum and trabecular bone parameters were negatively in DBA/2JRj mice. Fat mass was positively associated with cortical parameters and trabecular parameters in C57BL/6J and C3H /J mice, while negative correlations were seen between fat mass, cortical and trabecular parameters in DBA/2JRj mice.
In C57BL/6J and DBA/2JRj mice, myostatin levels did not change over time (Fig. 4). C3H/J mice had highest myostatin levels at 8 weeks, after this point they experienced decreases by 24 weeks Between strain comparisons revealed that at 16 and 24 weeks of age, C3H/J mice had lower myostatin levels than C57BL/6J and, to a less extent than DBA/2JRj mice (at 24 weeks, p = 0.079). At 24 weeks, there was also a weak strain effect indicating that DBA/2JRj mice had lower myostatin levels than C57BL/6J (p = 0.053). Data pooled for age confirmed these strain differences; C3H/J mice had the lowest myostatin levels, followed by DBA/2JRj and C57BL/6J mice.
In all mouse strains, periostin levels were greatest at 8 weeks and decreases occurred by 24 weeks of age (Fig. 4). Strain differences were seen only at 16 weeks, when DBA/2JRj mice had greater periostin levels than C3H/J mice and, to a less extent, than C57BL/6J (p = 0.065).

Discussion

This study presents baseline data that describe normal skeletal growth patterns and changes in body composition with age in 3 inbred mouse strains. We confirm and extend previous observations regarding strain specificity in bone microstructure. We also provide new evidence on inter- and intra-strain variability in the patterns (i.e., timing, magnitude, site) of cortical and trabecular bone development. Finally, this work advances our understanding regarding the relationships of skeletal microstructure, body composition, and relevant biomarkers (periostin and myostatin) and set the basis for delineating the contributions of these relationship in osteoporosis and sarcopenia.
We showed clear strain-specific phenotypic differences in cortical and trabecular bone microstructure. C3H/J mice had the thickest cortices at all skeletal sites followed by DBA/2JRj and C57BL/6J mice. Conversely, overall, C57BL/6J mice had smaller cortical bone area fraction and tissue mineral density than DBA/2JRj and C3H/J mice, whilst small differences were found between DBA/2JRj and C3H/J mice. These results confirm previous studies that compared C3H/J and C57BL/6J female [14, 17, 1921, 38] and male mice [15, 16, 18] and further indicate that male DBA/2JRj mice display intermediate values in cortical bone parameters.
The inferior cortical bone characteristics in C57BL/6J mice were counterbalanced by longer-term gains in the trabecular compartment. This is supported by the higher trabecular BV/TV and trabecular number, and lower trabecular separation seen in C57BL/6J mice compared to DBA/2JRj and C3H/J mice at least at 24 weeks of age. Our data are consistent with some [18, 21], but not all previous comparisons between C3H/J and C57BL/6J mice [14]. These discrepancies may be partially explained by differences in the methodologies used to assess bone structure (µCT vs. pQCT) and ages between ours and their experimental animals. The most pronounced characteristic of trabecular microstructure in DBA/2JRj mice was their consistently thinner trabeculae (vs. C57Bl/6J and C3H/J mice). Collectively, our work clarifies that strain differences are compartment specific and indicates that labelling a strain according to a sole complex trait such as bone mass may mask pronounced differences in cortical and trabecular bone properties.
We found that cortical and trabecular compartments may be differentially affected by age and that growth patterns differ among strains. In C57BL/6J mice, cortical and trabecular bone development peaked at the same timeframe (24 weeks of age). The same developmental pattern was seen for both cortical sites assessed. The vertebra and the proximal tibia shared similarities in trabecular bone development; however, in the distal femur we did not statistically identify age-related effects. The main mechanism of trabecular microstructure augmentation at the lumbar spine in C57BL/6J mice was thickening of the existing trabeculae, whereas trabecular number declined after 8 weeks of age. This decrease in trabecular number may be associated with altered remodeling processes, which aim to reorganize trabecular bone in response to prevalent loading conditions. In line with previous observations [29], the continuous increase in mean trabecular thickness may reflect the increased stress imposed to a reduced number of trabeculae. An alternative explanation why mean trabecular thickness increases, is that, as thinner trabeculae are resorbed, there is an increase in the average thickness of residual trabeculae. Previous observations have also shown that C57Bl/6J mice achieve peak structural, material and mechanical bone properties after 20 weeks of age [20, 28, 39]. In contrast, Glatt et al. studied age-related changes in bone morphology in male C57BL/6J mice and showed earlier increases (peak reached by 8 weeks) and subsequent maintenance (up to 24 weeks) in lumbar BV/TV, which were accompanied by elevations in trabecular number by 8 weeks and increases in trabecular thickness up to 16 weeks of age [29]. Small differences in growth patterns were seen in the distal femur and proximal tibia [29]. These discrepant findings can be in part attributed to differences in sampling frequency, intergroup variability and site evaluation (L4 vs. L5).
Normal growth patterns in DBA/2JRj and C3H/J mice remain poorly investigated. In DBA/2JRj mice, cortical bone maturity was reached at 24 weeks of age. Highest values of trabecular bone properties were, however, achieved earlier, between 8 and 16 weeks of age, depending on anatomical site, and these gains were associated with a higher number of trabeculae and favorable organization. In C3H/J mice, different growth patterns were observed at different anatomical sites. For example, maturity of cortical bone at the tibia was achieved at 24 weeks, whereas we did not statistically detect maximal values for most tibial trabecular parameters. This observation indicates that either there were no overt trabecular bone changes over time or that trabecular characteristics at this site peaked beyond the timeframe of our study. In contrast, at the femur, cortical thickness was greatest at 24 weeks, however, cortical bone area fraction decreased markedly after 16 weeks, suggesting some age-related thinning of the cortex. Skeletal maturity at the femoral trabecular sites was also achieved early, as indicated by peak femoral trabecular BV/TV at 8 weeks; this peak resulted primarily from increases in trabecular number rather than thickening. Trabecular bone properties in the lumbar spine reached maximal levels at 16 weeks and declined after this time point. Previously published data suggest that C3H/J mice display maximal skeletal morphological and biomechanical properties before 16 weeks of age [20]. We speculate that differences in load distribution characteristics in the different skeletal sites may contribute to the different patterns of age-related trabecular bone changes in C3H/J mice.
In addition to age- and strain- related differences in skeletal morphology, we explored how changes in body composition (muscle, fat) and relevant biochemical markers relate to skeletal characteristics during development. In human studies, there is consensus that lean mass is positively associated with bone parameters [47, 12]. Furthermore, some [8, 10], albeit not all [9], studies, have shown that peak muscle mass precedes peak bone mass, further supporting the notion that muscle accrual impacts bone acquisition. These positive association between lean mass and BMD have been largely attributed to the direct mechanical impact (muscle contractions, weight of muscle) of muscle on bone as described in the mechanostat theory [40].
We extend our understanding on the bone–muscle relationship during growth and propose that the relationship may be compartment dependent. We showed that the highest muscle mass and cortical bone properties occurred at 24 weeks of age in C3H/J and DBA/2JRj mice, whereas more variable cortical skeletal development patterns were seen in C3H/J mice. These results may reflect the observations that muscle mass increased progressively in C57BL/6J and DBA/2JRj mice, whereas it did not change over time in C3H/J mice. Due to our sampling frequency, it remains uncertain whether cortical bone acquisition follows peak muscle mass; nevertheless, our findings suggest that maximal values in both tissues may occur at the same timeframe. Our data could also be explained by available reports suggesting that mouse strains respond differently to mechanical stress. Indeed, C3H mice have been shown to be less sensitive to mechanical loading and unloading conditions than C57BL/6J mice [41, 42]. Alternatively, our finding may reflect collinear growth of muscle and bone tissues, regulated by genetic, endocrine and environmental factors [2, 32, 43].
Our findings do not support the notion that changes in muscle mass drive adaptations of trabecular bone during growth. For instance, overall, trabecular bone parameters reached maximum at 24 weeks in C57BL/6J, but at 8–16 weeks for DBA/2JRj mice, despite continuous increases in muscle mass by 24 weeks of age in both strains. These results may indicate that genetics, environmental and intrinsic factors and their complex interactions may override the effects of muscle mass on trabecular bone. It has been proposed that C3H/J mice possess sets of genes that lead to enhanced cortical bone properties and impaired trabecular bone [14, 16, 21]. Another possibility is that trabecular bone adaptations are driven by intrinsic bone factors. Indeed, the superior cortical bone structure in C3H/J mice is likely to carry a major part of mechanical load, leading to stress protective responses and resorption of trabecular bone [17, 21].
In addition to the mechanical interactions between bone and muscle, these tissues are also linked through secreted factors (i.e. myokines, osteokines, systemic hormones) [32, 33]. Myostatin, a potentially negative regulator of muscle growth and regeneration expressed predominantly in skeletal muscle, is a candidate of muscle–bone interactions. Age- and strain-related differences in myostatin levels were not reflected in the rather small muscle mass changes over time in either mouse strain. A potential explanation for these results is that myostatin abundance in serum may not reflect its activity, which is inhibited by several proteins (e.g., follistatin) [44]. Nevertheless, strain differences in myostatin levels might have contributed to the observed skeletal phenotypes during growth. C3H/J mice had the lowest myostatin levels and favorable cortical bone parameters, whereas C57BL/6J had the highest myostatin levels and the worst cortical microstructure. These observations are consistent with animal studies showing that myostatin knock out mice have increased periosteal circumference and tissue mineral density [33, 34].
Periostin is expressed in several tissues including bone and skeletal muscle [35]. In bone, periostin is a structural component of bone matrix, but also acts as a signaling molecule, which, through different pathways (i.e., sclerostin/Wnt-b catenin pathway), enhances osteoblast function, and hence, bone formation [35]. Deletion of the periostin gene in mice results in low bone mass, less favorable cortical bone structure and low bone strength in young adult mice [45, 46]. Periostin is also expressed by skeletal myofibers and has been shown to contribute to muscle development, regeneration and differentiation [36]. In our work, in all mouse strains, periostin levels were maximal at 8 weeks of age and declined thereafter, a finding consistent with the age-related decreases in periostin reported previously [35]. Theoretically, these results may reflect rapid stimulation of bone formation and/or muscle development at earlier time points. Nevertheless, given that periostin is non-specific to bone or muscle and serum periostin levels are reflective of the metabolism of other tissues as well; future studies are needed to elucidate the contribution of periostin to musculoskeletal phenotypes during development.
The relationship between fat mass and BMD in pediatric and young adult population is controversial, as available studies have demonstrated a positive, negative or no association [4, 6, 12]. It is plausible that these discrepancies somewhat reflect the complex interactions between bone and fat. Although the mechanical contribution of fat mass is limited to its weight, biochemical links between bone and fat are suggested to play a major role in the interplay of these tissues and are mediated by adipokines, osteokines, hormones and inflammatory factors [47]. Low body fat content and adiposity during growth may also impact the timing of maturation by affecting the secretion of molecules that exert positive (IGF-1), dual (leptin) or negative effects (tumor necrosis factor or TNF-a, interleukin 6 or IL-6) on bone [47, 48]. We speculate that this may be one of the reasons why DBA/2JRj mice and C3H/J mice (higher fat mass at early time points) experience earlier maturation than C57BL/6J mice. We also showed that fat mass increased progressively in all strains and paralleled the highest values in cortical thickness, despite variable developmental patterns in trabecular bone parameters. Further studies are needed to disentangle the effects of normal body fat levels on bone, together with the mechanisms that mediate these effects.

Strengths and Limitations

This study is strengthened by the powerful μCT imaging technique, which is non-destructive, accurate and widely used for the evaluation of three-dimensional bone microstructure [31]. Indeed, μCT measurements are highly correlated with measurements acquired by (static) histomorphometry, dual-energy X-ray absorptiometry (DXA) and pQCT [31, 49]. The simultaneous assessments of bone microstructure, body composition and bone/muscle-related biomarkers allowed us to provide novel insights into the relationship between bone, muscle and fat. Another strength of our work is that all mouse strains were studied at the same time under the same experimental conditions; therefore, confounding variations in diet composition, housing and handing conditions of the animals were reduced.
This study has some shortcomings. Given that our data are cross-sectional, rather than longitudinal; this work provides insights into normal growth patterns by inference. As a proxy of body composition, we calculated muscle and fat sum by summing the masses of individual muscles and fat depots. Assessment of body composition using validated methodologies would have been more accurate in determining age-related changes in muscle and fat mass [26, 50]. Mechanical testing was not directly performed to assess bone strength; nevertheless, bone microstructure has been shown to be a major determinant of bone stiffness and failure load during growth [51]. This work focused on skeletal development; therefore, we included mice at the age of rapid bone accrual (8–24 weeks). Although we were able to statistically detect maximal values in several bone microstructural parameters, we may have missed those that occurred earlier (< 8 weeks) or later (> 24 weeks) than the time of observation or small time differences, which occurred between 8 and 24 weeks of age, but did not reach statistical significance.

Conclusions

This study provides a comprehensive characterization of normal skeletal development and body composition changes in three male inbred mouse strains. Our data confirm previous observations showing that C3H/J mice display the best cortical bone parameters, clarify earlier inconsistencies by demonstrating that C57BL/6J have favorable trabecular bone parameters, and suggest that the DBA/2JRj mice present with intermediate values. We further support strain differences in skeletal growth patterns; these differences affect the timing of development (i.e., C57BL/6J mice mature later than DBA/2JRj and C3H/J mice) and are compartment and site specific. Strain differences in body composition were observed early in the study and, albeit they were less pronounced than strain effects on skeletal phenotypes, they appeared to influence skeletal maturity. We anticipate that this work will aid in the informed selection of background strains and ages in genetic manipulations, lifestyle, pharmacological, and surgical interventions, will contribute to the interpretations of existing studies and will guide future research on the molecular and cellular regulation of peak bone mass.

Acknowledgements

Open access funding provided by Medical University of Vienna. MP is the recipient of a postdoctoral Ernst Mach Fellowship (ICM-2018-10048, Austrian Agency for International Cooperation in Education and Research, Vienna, Austria). The kits for periostin analysis were kindly donated by Biomedica Medizinprodukte GmbH, Vienna, Austria.

Compliance with Ethical Standards

Conflict of interest

Katharina Kerschan-Schindl received research support and/or remuneration from Amgen GmbH, Lilly GmbH, Merck, Sharp & Dohme GmbH, Roche Austria, and Servier Austria. Peter Pietschmann has received research support and/or remuneration from Amgen GmbH, Biomedica Medizinprodukte, BE Perfect Eagle, Fresenius Kabi GmbH, Medahead GmbH, Mylan GmbH and UCB Pharma. Maria Papageorgiou, Ursula Föger-Samwald, Katharina Wahl have no conflict of interest to declare.

Human and Animal Rights and Informed Consent

All procedures were conducted in accordance with institutional and national guidelines and regulations.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
3.
Zurück zum Zitat Bonjour JP, Chevalley T, Ferrari S, Rizzoli R (2009) The importance and relevance of peak bone mass in the prevalence of osteoporosis. Salud Publica Mex 51(Suppl 1):S5–17PubMed Bonjour JP, Chevalley T, Ferrari S, Rizzoli R (2009) The importance and relevance of peak bone mass in the prevalence of osteoporosis. Salud Publica Mex 51(Suppl 1):S5–17PubMed
10.
Zurück zum Zitat Iuliano-Burns S, Mirwald RL, Bailey DA (2001) Timing and magnitude of peak height velocity and peak tissue velocities for early, average, and late maturing boys and girls. Am J Hum Biol 13(1):1–8CrossRef Iuliano-Burns S, Mirwald RL, Bailey DA (2001) Timing and magnitude of peak height velocity and peak tissue velocities for early, average, and late maturing boys and girls. Am J Hum Biol 13(1):1–8CrossRef
17.
Zurück zum Zitat Akhter MP, Iwaniec UT, Covey MA, Cullen DM, Kimmel DB, Recker RR (2000) Genetic variations in bone density, histomorphometry, and strength in mice. Calcif Tissue Int 67(4):337–344CrossRef Akhter MP, Iwaniec UT, Covey MA, Cullen DM, Kimmel DB, Recker RR (2000) Genetic variations in bone density, histomorphometry, and strength in mice. Calcif Tissue Int 67(4):337–344CrossRef
23.
Zurück zum Zitat Lionikas A, Blizard DA, Vandenbergh DJ, Stout JT, Vogler GP, McClearn GE et al (2006) Genetic determinants of weight of fast- and slow-twitch skeletal muscles in old mice. Mamm Genome 17(6):615–628CrossRef Lionikas A, Blizard DA, Vandenbergh DJ, Stout JT, Vogler GP, McClearn GE et al (2006) Genetic determinants of weight of fast- and slow-twitch skeletal muscles in old mice. Mamm Genome 17(6):615–628CrossRef
33.
Zurück zum Zitat Elkasrawy MN, Hamrick MW (2010) Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact 10(1):56–63PubMedPubMedCentral Elkasrawy MN, Hamrick MW (2010) Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact 10(1):56–63PubMedPubMedCentral
37.
Zurück zum Zitat Silva MJ, Eekhoff JD, Patel T, Kenney-Hunt JP, Brodt MD, Steger-May K et al (2019) Effects of high-fat diet and body mass on bone morphology and mechanical properties in 1100 advanced intercross mice. J Bone Miner Res 34(4):711–725CrossRef Silva MJ, Eekhoff JD, Patel T, Kenney-Hunt JP, Brodt MD, Steger-May K et al (2019) Effects of high-fat diet and body mass on bone morphology and mechanical properties in 1100 advanced intercross mice. J Bone Miner Res 34(4):711–725CrossRef
38.
Zurück zum Zitat Sheng MH, Baylink DJ, Beamer WG, Donahue LR, Lau KH, Wergedal JE (2002) Regulation of bone volume is different in the metaphyses of the femur and vertebra of C3H/HeJ and C57BL/6J mice. Bone 30(3):486–491CrossRef Sheng MH, Baylink DJ, Beamer WG, Donahue LR, Lau KH, Wergedal JE (2002) Regulation of bone volume is different in the metaphyses of the femur and vertebra of C3H/HeJ and C57BL/6J mice. Bone 30(3):486–491CrossRef
50.
Zurück zum Zitat Halldorsdottir S, Carmody J, Boozer CN, Leduc CA, Leibel RL (2009) Reproducibility and accuracy of body composition assessments in mice by dual energy x-ray absorptiometry and time domain nuclear magnetic resonance. Int J Body Compos Res 7(4):147–154PubMedPubMedCentral Halldorsdottir S, Carmody J, Boozer CN, Leduc CA, Leibel RL (2009) Reproducibility and accuracy of body composition assessments in mice by dual energy x-ray absorptiometry and time domain nuclear magnetic resonance. Int J Body Compos Res 7(4):147–154PubMedPubMedCentral
Metadaten
Titel
Age- and Strain-Related Differences in Bone Microstructure and Body Composition During Development in Inbred Male Mouse Strains
verfasst von
Maria Papageorgiou
Ursula Föger-Samwald
Katharina Wahl
Katharina Kerschan-Schindl
Peter Pietschmann
Publikationsdatum
04.01.2020
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 4/2020
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-019-00652-8

Weitere Artikel der Ausgabe 4/2020

Calcified Tissue International 4/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.